Publications by authors named "Catherine Blaker"

Claim this Profile
T
The interplay between FOXO3 and FOXM1 influences sensitivity to AKT inhibition in PIK3CA and PIK3CA/PTEN altered estrogen receptor positive breast cancer.
Valentina Cutano, Ming Li Chia, Eleanor M Wigmore, Lorna Hopcroft, Stuart C Williamson, Catherine Blaker

NPJ Breast Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unlocking the diagnostic power of plasma extracellular vesicle miR-200 family in pancreatic ductal adenocarcinoma.
Daniel S K Liu, Jisce R Puik, Bhavik Y Patel, Morten T Venø, Mahrou Vahabi, Catherine Blaker

J Exp Clin Cancer Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models.
Lorna Hopcroft, Eleanor M Wigmore, Stuart C Williamson, Susana Ros, Cath Eberlein, Catherine Blaker

NPJ Breast Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models.
Lorna Hopcroft, Eleanor M Wigmore, Stuart C Williamson, Susana Ros, Cath Eberlein, Catherine Blaker

NPJ Breast Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models.
Lorna Hopcroft, Eleanor M Wigmore, Stuart C Williamson, Susana Ros, Cath Eberlein, Catherine Blaker

NPJ Breast Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upregulation of β-catenin due to loss of miR-139 contributes to motor neuron death in amyotrophic lateral sclerosis.
Sophie Hawkins, Seema C Namboori, Ammarah Tariq, Catherine Blaker, Christine Flaxman

Stem Cell Reports· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis